Sietze Reitsma
.ical

Sessions

09-09
14:00
30min
Personalizing therapy in CRS: From Cytokins to clinical choices
Sietze Reitsma, Stefania Gallo

Personalizing therapy in CRS: From Cytokins to clinical choices

Rhinology
Rhinology 1 (ICC - B2 level BEYAZIT)
09-11
11:15
90min
CSR Pathophysiology Update 2026
Claus Bachert, Sietze Reitsma, Martin Desrosiers, Robert Kern, Wilma Terezinha Anselmo Lima, Kenichi Takano

CSR Pathophysiology Update 2026. CSR Pathophysiology Update 2026

Rhinology
Rhinology 3 (HILTON-Connie 1)
09-11
14:30
30min
What's New in CRS? Updates from Recent Clinical Trials and Consensus Statements
Sietze Reitsma, Anda Gata
Yo-IFOS (Young IFOS)
Young IFOS 2
09-11
17:30
30min
Should we reduce dosing frequency in Biologic responders: Pros and Cons?
Valerie Hox, Sietze Reitsma, David Liu

Should we reduce dosing frequency in Biologic responders: Pros and Cons?

Rhinology
Rhinology 1 (ICC - B2 level BEYAZIT)
09-12
14:30
90min
Real world evidence in biological therapy for CRSwNP: Current status in 2026
Ludger Klimek, Sietze Reitsma, Jan Vodička, Dana Crosby, Stefania Gallo, Syed Ahamed Peer Mohamed, Peter Hellings, Carl Philpott

Real world evidence in biological therapy for CRSwNP: Current status in 2026

Rhinology
Rhinology 3 (HILTON-Connie 1)